Company

RaND Biosciences Co., Ltd.

RaND Biosciences develops drug discovery technology and anticancer medicines.

About

RaND Biosciences develops anticancer drugs for solid cancers, lung cancer, and biliary tract cancer through a drug discovery platform. Founded in 2015, it is based in Daejeon, South Korea. In August 2021, it raised KRW 3 billion from Kukdong Co., Ltd. As of May 2023, its work was in Phase 1 clinical trials.

1Funding rounds

1Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in